This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Valorisation Hsj, Limited Partnership, Valorisation-Recherche, Limited Partnership. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Jerome Tanner: Innovator in Antigenic Epitope Research
Introduction
Jerome Tanner is a notable inventor based in Dollard-des-Ormeaux, Canada. He has made significant contributions to the field of immunology through his innovative research and patenting of antigenic epitopes. His work focuses on developing peptides that can induce the production of neutralizing antibodies against herpesviruses, particularly the Epstein-Barr virus (EBV).
Latest Patents
Jerome Tanner holds a patent titled "Antigenic epitopes from EBV gp350/220 and uses thereof." This invention relates to a peptide that comprises specific amino acid sequences designed to bind to monoclonal antibodies. The peptide can be utilized for immunizing or vaccinating animals against gp350-expressing herpesviruses. Additionally, it serves as a tool for detecting the presence of neutralizing antibodies in samples. Tanner's patent is a significant advancement in the field of vaccine development and immunological research, with the potential to improve therapeutic strategies against EBV.
Career Highlights
Throughout his career, Jerome Tanner has worked with various organizations, including Valorisation Hsj, Limited Partnership and Valorisation-Recherche, Limited Partnership. His experience in these companies has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Jerome Tanner has collaborated with notable colleagues such as Jing Hu and Mathieu Coinçon. These partnerships have enhanced his research capabilities and fostered innovation in the development of immunological solutions.
Conclusion
Jerome Tanner's contributions to the field of immunology through his patent on antigenic epitopes highlight his role as an innovator. His work not only advances scientific understanding but also has practical applications in vaccine development.